A new open access journal for Cochrane: Cochrane Evidence Synthesis and Methods

ESM logo

Cochrane’s first open access journal, Cochrane Evidence Synthesis and Methods, has opened for submissions! Working in conjunction with our publisher, Wiley, this journal strengthens Cochrane’s ability to meet our stakeholders’ needs and publish different types of evidence synthesis beyond systematic reviews. It will also include methods research evaluating how evidence syntheses is planned, produced and disseminated, and research articles on critical areas for evidence synthesis, such as, priority setting, consumer involvement, and research integrity.  

Cochrane has over 100,000 members and contributors across an established global network who publish their systematic reviews in the Cochrane Database of Systematic Reviews. This new journal opens up opportunities for these members, and researchers new to Cochrane, to publish research outputs that go beyond Cochrane systematic reviews, which reflects the interests, talents and expertise of this global network and beyond. The journal aims to further develop the evidence base for how we produce and publish evidence synthesis, share best practice, case studies and commentaries.  

Michael Brown, Editor, Cochrane Evidence Synthesis and Methods (responsible for the content and development of the journal), and Professor at Michigan State University, USA, explains,The agility involved means we can collaborate more closely with guideline developers, decision makers and funders through publication of evidence syntheses directly relevant to their specific interests. We hope the community is as excited as we are to be able to publish this range of research relevant to evidence synthesis in a journal with Cochrane’s philosophy for transparency, integrity, and independence.”


Karla Soares-Weiser, Editor-in-Chief, Cochrane, adds, “This is an exciting milestone for Cochrane as Cochrane Evidence Synthesis and Methods allows us to publish a wider range of evidence products that meets a more diverse range of stakeholder needs. It will enable Cochrane to better respond to important global health and social care needs and influence health decisions that go beyond the remit of systematic reviewing alone.”

Ella Flemyng, Editorial Product Lead, Cochrane, explains why this new journal is important for the field, “Cochrane Evidence Synthesis and Methods welcomes innovative ideas and is not afraid to trial new ways of publishing. This includes showcasing practices that support research integrity, embedding consumer involvement within the journal, piloting how to better visualise research, and improving peer review - as a few examples.”

For more information visit:

Tuesday, November 15, 2022